Cargando…
Genetic variants in p53 signaling pathway genes predict chemotherapy efficacy in colorectal cancer
BACKGROUND: The murine double minute‐2 gene (MDM2) was originally identified as predicting chemotherapy efficacy. However, little is known regarding the association between single nucleotide polymorphisms (SNPs) in the p53 signaling pathway and prognosis/chemotherapy sensitivity in colorectal cancer...
Autores principales: | Zhang, Ke, Meng, Yixuan, Cao, Xiangming, Xu, Ye, Du, Mulong, Wu, Yuan, Liu, Lingxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601596/ https://www.ncbi.nlm.nih.gov/pubmed/31090204 http://dx.doi.org/10.1002/cam4.2215 |
Ejemplares similares
-
Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
por: Ren, Anjing, et al.
Publicado: (2019) -
Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk
por: Cao, Dongliang, et al.
Publicado: (2020) -
Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2019) -
Functional genetic variant of HSD17B12 in the fatty acid biosynthesis pathway predicts the outcome of colorectal cancer
por: Lin, Yu, et al.
Publicado: (2020) -
Polymorphism rs2682818 in miR‐618 is associated with colorectal cancer susceptibility in a Han Chinese population
por: Chen, Yuetong, et al.
Publicado: (2018)